Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-20-058217

Chief Executive Officer acquired 14,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. Chief Executive Officer 2020-05-05 Option exercise +14,100 $9.39 $132,399 714,682 D
Derivatives
Chan Phillip P. Chief Executive Officer 2020-05-05 Option exercise · Stock Option (right to buy) −14,100 0 D
Loading xslF345X03/tm2019006d1_4.xml…